About ChromaDex
ChromaDex is a publicly listed company based in Irvine (United States) founded in 1999. Nutritional ingredients for health and wellness are developed. ChromaDex has raised $3.35 million across 23 funding rounds from investors including dsm-firmenich, Hercules Capital and Western Alliance Bank. The company has 228 employees. ChromaDex offers products and services including Tru Niagen, Niagen Plus, Niagen Ingredients, and Reference Standards. Its focus areas include Life Sciences, Nutraceuticals Tech, Dietary Supplements and Disease Specific. Its legal entity is Niagen Bioscience. Its competitors include LifeVantage and Bloom Nutrition.
Company details
ChromaDex was founded in 1999 in Irvine, United States, within the health and wellness sector. Nutritional ingredients are developed by the company, with operations centered on research into nicotinamide adenine dinucleotide (NAD), levels of which decline with age. Niagen is provided as the sole active ingredient in the consumer product Tru Niagen, supporting broader efforts in nutritional innovation.
- Headquarters Irvine, United States
- Employees 228
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website chromadex.com
- Social LinkedIn X Facebook
- Legal Name Niagen Bioscience
- Total Equity Funding$3.35M (USD)
in 23 rounds
- Latest Funding Round$16.39M (USD), Post-IPO
Feb 2021
- Investorsdsm-firmenich
& 4 more
- Employee Count228
Products & Services of ChromaDex
ChromaDex offers a comprehensive portfolio of products and services, including Tru Niagen, Niagen Plus, Niagen Ingredients, and Reference Standards.
NAD-boosting supplement for enhancing cellular health and longevity.
Advanced therapy for fast-acting NAD+ enhancement in health enthusiasts.
Proprietary components for dietary supplements and pharmaceutical use.
Standards for scientific studies in NAD+ and related fields.
Funding Insights of ChromaDex
ChromaDex has successfully raised a total of $3.35M across 23 strategic funding rounds. The most recent funding activity was a Post-IPO round of $16.39 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.35M
- Total Rounds 23
- Last Round Post-IPO — $16.39M
- First Round $39,000
(Feb 2007)
- Investors Count 5
Latest 10 of 23 funding rounds of ChromaDex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2021 | $16.39M | Post-IPO | – | – | – |
| May 2020 | $5M | Post-IPO | – | – | – |
| Aug 2019 | $7M | Post-IPO | – | – | – |
| May 2019 | $10M | Post-IPO | – | – | – |
| Nov 2017 | $23M | Post-IPO | – | – | – |
| Aug 2017 | $5.11M | Post-IPO | – | – | – |
| Jun 2017 | $25M | Post-IPO | – | – | |
| May 2017 | $3.5M | Post-IPO | – | – | – |
| Nov 2016 | $5M | Debt – Conventional | – | – | |
| Mar 2016 | $500,000 | Post-IPO | – | – | – |
5 investors in total: 5 institutional.
Investors in ChromaDex
ChromaDex has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include dsm-firmenich, Hercules Capital and Western Alliance Bank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Horizons Ventures is focused on investing in deep science and technology. | horizonsventures.com | Hong Kong, China | ||
Venture debt financing is provided to companies in multiple sectors. | 2003 | htgc.com | Palo Alto, United States | |
Commercial banking services, including loans and treasury management, are provided. | 2001 | westernalliancebancorporation.com | Phoenix, United States | |
Health, nutrition, and bioscience solutions are delivered worldwide. | 1902 | dsm.com | Heerlen, Netherlands | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for ChromaDex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ChromaDex
40 people are tracked at ChromaDex (13 in leadership, 14 in board & advisors, 13 in team); the tracked headcount is 228.
| Name | Role | Group |
|---|---|---|
Robert Fried | CEO | Leadership |
Wesley Yu | Vp, Finance | Leadership |
Tommy Uong | Director Of Business Development | Leadership |
Myron K. | Director Of Finance | Leadership |
Cherí Thomas | Director Of Customer Care | Leadership |
Mona Rosene Ms, Rd | Global Director, Scientific Affairs | Leadership |
James D. McChesney | Chief Scientific Officer | Leadership |
Jenny Robles | Director, People Matter(s) | Leadership |
Yasmeen Nkrumah-Elie | Senior Global Director For External Research (preclinical And Clinical) | Leadership |
Jason Brody | Creative Director | Leadership |
Erika Shioya | Director Of Global Regulatory Affairs | Leadership |
Angie Beaudreau | Director, ERP Systems | Leadership |
Amanda Storjohann | Director, Product Formulation | Leadership |
Brunie H. Felding | Scientific Advisor | Board & advisors |
Frank L. Jaksch Jr. | Co-Founder & Chairman | Board & advisors |
Steven D. Rubin | Non-Executive Director | Board & advisors |
Wendy Yu | Non-Executive Director | Board & advisors |
Charles Brenner | Chief Scientific Advisor | Board & advisors |
Rudolph Tanzi | Scientific Advisor | Board & advisors |
John Walker | Scientific Advisor | Board & advisors |
20 more people are available in the full profile.
Complete people profiles for ChromaDex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ChromaDex
4 dated milestones of ChromaDex across 22 years, from founding to its latest funding, stage changes and deals.
- Founded ChromaDex is founded.
- Funding First funding round of $39K.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $16.4M.
Competitors of ChromaDex
ChromaDex has 2 listed competitors in our database. They include LifeVantage and Bloom Nutrition.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lifevantage.com | 2003 | Monroe, United States | 248 | Nutritional products for various health ailments are provided. | ||
| bloomnu.com | 2019 | Venice, United States | 41 | Health and wellness nutritional supplements are provided by Bloom Nutrition. |
Detailed competitors of ChromaDex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ChromaDex
The website of ChromaDex (chromadex.com) receives about 8.7K visits a month.
- Monthly visits8.7K
▲ 31.4% vs previous month
Websites whose visitors overlap most with ChromaDex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| usp.org | 100% | 538.7K | #106,934 | View details | |
kaplanclinic.com | kaplanclinic.com | 98% | #2,122,115 | – | |
| revivme.com | 96% | #861,200 | View details | ||
| bio-quant.com | 86% | View details | |||
| arraybiopharma.com | 86% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 18 similar websites and full traffic analytics for ChromaDex
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as ChromaDex (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | 910 | ||
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | |||
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Chromadex
Complete news archive for ChromaDex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ChromaDex
ChromaDex was founded in 1999 and raised its 1st funding round 8 years after it was founded.
ChromaDex is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
ChromaDex is a funded company, having raised a total of $3.35M across 23 funding rounds to date. The company's 1st funding round was a Post-IPO of $500K, raised on Feb 2007.
ChromaDex has 228 employees.
ChromaDex was founded in 1999 in Irvine, United States, within the health and wellness sector. Nutritional ingredients are developed by the company, with operations centered on research into nicotinamide adenine dinucleotide (NAD), levels of which decline with age. Niagen is provided as the sole active ingredient in the consumer product Tru Niagen, supporting broader efforts in nutritional innovation.
ChromaDex's top competitors include LifeVantage and Bloom Nutrition.
ChromaDex offers Tru Niagen, Niagen Plus, Niagen Ingredients, and Reference Standards.
ChromaDex has 5 investors. Key investors include dsm-firmenich, Hercules Capital, Western Alliance Bank, Horizons Ventures, and National Science Foundation.
ChromaDex operates through Niagen Bioscience.